Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alfa-2b”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT02185261
What this trial is testing

Interferon α for the Therapy of Minimal Residual Disease

Who this might be right for
Leukemia
Peking University People's Hospital 81
Large-scale testing (Phase 3)Study completedNCT00686517
What this trial is testing

Evaluation of Peginterferon Alfa-2b Monotherapy and Combination With Ribavirin in Participants With Acute Hepatitis C (P03552/MK-4031-137)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 130
Testing effectiveness (Phase 2)Study completedNCT00396019
What this trial is testing

Study of PEG-Intron for Plexiform Neurofibromas

Who this might be right for
Plexiform Neurofibroma
University of Pittsburgh 86
Large-scale testing (Phase 3)Study completedNCT00299936
What this trial is testing

Comparison of PEG-Intron and Two Different Doses of Ribavirin for the Treatment of Chronic Hepatitis C In Treatment Naïve Subjects

Who this might be right for
Chronic Hepatitis C
Weill Medical College of Cornell University 5,000
Testing effectiveness (Phase 2)Study completedNCT00068575
What this trial is testing

Chemotherapy, Interferon Alfa, and Radiation Therapy in Treating Patients Who Have Undergone Surgery For Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
M.D. Anderson Cancer Center 29
Testing effectiveness (Phase 2)Study completedNCT00610857
What this trial is testing

Safety and Efficacy of Combination HDI and Anti-CTLA4 for Recurrent Inoperable Stage III or Stage IV Melanoma

Who this might be right for
Melanoma
Ahmad Tarhini 37
Early research (Phase 1)Study completedNCT01432535
What this trial is testing

Pharmacokinetics of Peginterferon Alfa-2b in Participants With Moderate and Severe Renal Impairment (P05655)

Who this might be right for
Renal Insufficiency
Merck Sharp & Dohme LLC 25
Large-scale testing (Phase 3)WithdrawnNCT00381017
What this trial is testing

Effects of Low-dose Maintenance Peg Interferon Alfa-2b Therapy Versus Supportive Care in Patients With Cirrhotic Hepatitis C With HIV (Study P04371)

Who this might be right for
Hepatitis CLiver CirrhosisHIV Infections
Merck Sharp & Dohme LLC
Testing effectiveness (Phase 2)Study completedNCT02001818
What this trial is testing

Pegylated Interferon Alfa-2b and Nilotinib for Augmentation of Complete Molecular Response in Chronic Myeloid Leukaemia

Who this might be right for
Chronic Myeloid Leukaemia
Australasian Leukaemia and Lymphoma Group 60
Large-scale testing (Phase 3)Ended earlyNCT01641926
What this trial is testing

The Safety and Efficacy of Pegylated Inferferon Alfa-2b (PEG-Intron™) Versus Pegylated Interferon Alfa-2a (PEGASYS™) in Participants With Chronic Hepatitis B (P08450)

Who this might be right for
Hepatitis B, Chronic
Merck Sharp & Dohme LLC 402
Large-scale testing (Phase 3)Study completedNCT02634294
What this trial is testing

Peg Interferon α-2b for Relapsed Hematological Malignancies After Allo-HSCT

Who this might be right for
Hematological NeoplasmsRecurrence
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 30
Large-scale testing (Phase 3)Study completedNCT00378599
What this trial is testing

Effects of Pegylated Interferon Alfa-2b and Ribavirin After Orthotopic Liver Transplantation in Subjects With Chronic Hepatitis C Recurrence (P04590AM3)(COMPLETED)

Who this might be right for
Liver TransplantationHepatitis C, ChronicLiver Cirrhosis
Merck Sharp & Dohme LLC 125
Large-scale testing (Phase 3)Study completedNCT00780416
What this trial is testing

Efficacy and Safety of MP-424/Peginterferon Alfa-2b/Ribavirin Combination in Treatment-Naïve Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C
Tanabe Pharma Corporation 189
Post-approval studies (Phase 4)Not Yet RecruitingNCT06900166
What this trial is testing

Pegylated Interferon Alfa-2b in Reducing Relapse Rates After Nucleos(t)ide Analogue Withdrawal in HBeAg-negative CHB Patients with Low Level HBsAg

Who this might be right for
Chronic Hepatitis B
Huashan Hospital 360
Large-scale testing (Phase 3)WithdrawnNCT01641666
What this trial is testing

Safety and Tolerability of Boceprevir in Combination With Peginterferon Alfa-2b Plus Ribavirin for the Treatment of Vietnamese Subjects With Chronic Hepatitis C Genotype 1 (P08599)

Who this might be right for
Chronic Hepatitis C
Merck Sharp & Dohme LLC
Large-scale testing (Phase 3)Study completedNCT00005966
What this trial is testing

Interferon Alfa-2b With or Without Thalidomide in Treating Patients With Metastatic or Unresectable Kidney Cancer

Who this might be right for
Kidney Cancer
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00003656
What this trial is testing

Tretinoin Plus Interferon Alfa in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Weill Medical College of Cornell University 26
Testing effectiveness (Phase 2)Ended earlyNCT01964300
What this trial is testing

Peginterferon Alfa-2b in Younger Patients With Craniopharyngioma That is Recurrent or Cannot Be Removed By Surgery

Who this might be right for
Childhood Craniopharyngioma
Pediatric Brain Tumor Consortium 19
Early research (Phase 1)Ended earlyNCT00701298
What this trial is testing

Decitabine With or Without Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT00292084
What this trial is testing

An Extension Study to Evaluate the Safety and Efficacy of Celgosivir and Peginterferon Alfa-2b, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype 1 Infection

Who this might be right for
Hepatitis C, Chronic
BioWest Therapeutics Inc 60
Next Page